Study guide
2.3 Impaired Pharmacist Recovery Program & Duty to Report
Oklahoma MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Overview
1.1 Oklahoma MPJE Format, Blueprint & Passing Standards 1.2 Navigating Oklahoma & Federal Pharmacy Law Hierarchy
2 Chapter 2: State Board Governance & Administrative Framework
2.1 Oklahoma State Board of Pharmacy Structure & Powers 2.2 Disciplinary Procedures, Sanctions & Hearings 2.3 Impaired Pharmacist Recovery Program & Duty to Report
3 Chapter 3: Pharmacist Licensure & Continuing Education
3.1 Pharmacist Licensure Qualifications & Examination Rules 3.2 Reciprocity & Foreign Pharmacy Graduates 3.3 Annual License Renewal & Continuing Education Mandates 3.4 Inactive Status, Late Renewal & License Reinstatement
4 Chapter 4: Pharmacy Interns, Preceptors & Supportive Personnel
4.1 Pharmacy Intern Qualifications & Preceptor Standards 4.2 Experiential Intern Hours, Credit & Board Reporting 4.3 Pharmacy Technician Permitting & Training Requirements 4.4 Pharmacist-to-Technician Ratios & Scope of Supportive Duties
5 Chapter 5: Prescription Validity & Prescriber Authority
5.1 Legal Requirements of a Valid Prescription 5.2 Prescriptive Authority & Scopes of Practice in Oklahoma 5.3 The Pharmacist's Corresponding Responsibility & Red Flags 5.4 Out-of-State, Military & Foreign Prescriptions
6 Chapter 6: Electronic Prescribing & Controlled Substance Schedules
6.1 Oklahoma Electronic Prescribing Mandate (EPCS) 6.2 Federal & Oklahoma Controlled Dangerous Substance Schedules 6.3 Scheduled Listed Chemical Products (SLCP) & Pseudoephedrine Sales 6.4 Schedule V Non-Prescription (Exempt) Controlled Substances
7 Chapter 7: Controlled Substance Dispensing & Opioid Limits
7.1 Schedule II Prescribing & Dispensing Regulations 7.2 Emergency Schedule II Oral Authorizations 7.3 Partial Filling of Schedule II Prescriptions (CARA & Title 63) 7.4 Oklahoma Opioid Prescribing Limits for Acute Pain
8 Chapter 8: Patient Counseling, Safety & Clinical Pharmacy Services
8.1 Patient Counseling Mandates & OBRA '90 8.2 Prospective Drug Utilization Review (DUR) Requirements 8.3 Pharmacist Immunization Administration Authority 8.4 Naloxone Standing Orders, Overdose Prevention & Clinical Protocols 8.5 Patient Confidentiality, HIPAA Privacy & Health-Record Protection
9 Chapter 9: Dispensing Standards, Generic Substitution & Labeling
9.1 Oklahoma Generic Drug Substitution Laws (Orange Book) 9.2 Biosimilar & Interchangeable Biological Products (Purple Book) 9.3 Prescription Refill Limits & Emergency Maintenance Fills 9.4 Prescription Labeling, Poison Prevention Packaging (PPPA) & USP Standards 9.5 Expired, Adulterated, Misbranded & Recalled Drug Products 9.6 Nonprescription Drug Labeling, Packaging & Repackaging 9.7 Returning & Reusing Drugs: Return-to-Stock, Donation & Disposal
10 Chapter 10: Prescription Transfers, Delivery & Monitoring Systems
10.1 Prescription Transfer Rules (Controlled vs. Non-Controlled) 10.2 Oklahoma Prescription Monitoring Program (OK PMP / PMP AWARxE) 10.3 Central Fill, Mail-Order & Prescription Delivery Regulations 10.4 Automated Dispensing Systems (ADS) & Remote Pharmacy Services
11 Chapter 11: Pharmacy Permits, Facilities & Operational Standards
11.1 Oklahoma Pharmacy Licenses & Permits 11.2 Pharmacist-in-Charge (PIC) Governance & Requirements 11.3 Physical Plant, Security & Sanitation Standards 11.4 Pharmacy Permanent Closing & Change of Ownership
12 Chapter 12: Controlled Substance Management, Ordering & Security
12.1 Pharmacy DEA & OBNDD Registration Requirements 12.2 Controlled Substance Ordering (DEA Form 222 & CSOS) 12.3 Controlled Substance Physical Inventory Requirements 12.4 Theft, Significant Loss & CDS Destruction (DEA Form 106 & Form 41)
13 Chapter 13: Compounding Standards & Institutional Practice
13.1 Non-Sterile (USP <795>) & Sterile (USP <797>) Compounding 13.2 Hazardous Drug Handling (USP <800>) 13.3 Hospital & Institutional Pharmacy Operations (Hospital Pharmacies & Drug Rooms) 13.4 Nuclear, Charitable & Specialty Pharmacy Standards
2.3 Impaired Pharmacist Recovery Program & Duty to Report
Key Takeaways Explain This Topic AI
The Oklahoma Pharmacists Recovery Program (PRP) provides confidential clinical assessment, rehabilitation, and multi-year recovery monitoring for impaired practitioners.
Voluntary self-referral preserves participant confidentiality and avoids public discipline if entered prior to investigation and without independent patient harm or criminal diversion.
Board-mandated participation occurs via disciplinary orders, requiring strict compliance with 3-to-5 year monitoring agreements to maintain or restore licensure.
Licensees and Pharmacists-in-Charge have an affirmative statutory duty to report colleagues practicing while impaired, with good-faith reporters protected from civil liability.
Any positive drug screen, refusal of care, or contract breach triggers immediate notification to the Board Executive Director and emergency license suspension.
Last updated: August 2026
Impaired Pharmacist Recovery Program & Duty to Report
Quick Summary: Substance use disorders, alcoholism, chemical dependency, and severe psychiatric illnesses among pharmacy professionals represent grave threats to public safety. The Oklahoma State Board of Pharmacy recognizes chemical dependency as a treatable illness and authorizes the Impaired Pharmacist Recovery Program (often operated as the Pharmacists Recovery Program / PRP / Oklahoma Pharmacists Helping Pharmacists / OPHP) . Practitioners who voluntarily self-report prior to regulatory investigation or patient harm can receive confidential rehabilitation and monitoring without public disciplinary action. Conversely, practitioners entering via Board disciplinary orders must fulfill rigorous, multi-year recovery contracts (typically 3 to 5 years). Oklahoma law imposes an affirmative duty on all licensees to report impaired colleagues , with immunity protections for good-faith reporting.
1. Regulatory Rationale & The Disease Concept of Impairment
Pharmacists hold unprecedented access to controlled dangerous substances (CDS), creating unique professional risks for chemical dependency. Recognizing that substance use disorder is a progressive, chronic medical condition rather than merely a moral failing, Oklahoma pharmacy jurisprudence balances two vital objectives:
Public Protection: Ensuring that no impaired individual dispenses medications or exercises clinical judgment while compromised.
Professional Rehabilitation: Providing a confidential, structured path for impaired practitioners to undergo treatment, achieve sustained recovery, and safely re-enter the profession.
Under Title 59 O.S. § 353.202 et seq. and Board rules in OAC 535:10-3-1.1 , the Board recognizes approved peer assistance programs to evaluate, treat, and monitor impaired pharmacists, pharmacy interns, and registered pharmacy technicians.
2. Voluntary Self-Referral vs. Board-Ordered Disciplinary Monitoring
A central distinction on the Oklahoma MPJE is the legal difference between voluntary self-enrollment and Board-mandated disciplinary participation . ┌────────────────────────────────────────┐
- │ Impaired Pharmacy Professional │
- └───────────────────┬────────────────────┘
- │
- ┌──────────────────────────────┴──────────────────────────────┐
- ▼ ▼
- ┌───────────────────────────┐ ┌───────────────────────────┐
- │ Voluntary Self-Referral │ │ Board-Ordered Mandate │
- └─────────────┬─────────────┘ └─────────────┬─────────────┘
- │ │
- ┌───────────────┴───────────────┐ ┌───────────────┴───────────────┐
- ▼ ▼ ▼ ▼
- ┌──────────────┐ ┌─────────────────┐ ┌──────────────┐ ┌─────────────────┐
- │ Confidential │ │ Non-Disciplinary│ │Public Record │ │ Disciplinary │
- │ (No Public │ │ (Provided No │ │(Order on │ │ Sanction │
- │ Board Order)│ │ Harm/Diversion)│ │ Board Record)│ │ (Probation/Stay)│
- └──────────────┘ └─────────────────┘ └──────────────┘ └─────────────────┘
- Path A: Voluntary Self-Referral (Confidential Track)
Eligibility: A pharmacist, intern, or technician who recognizes their impairment contacts the recovery program directly or self-reports before a formal Board investigation, arrest, or dispensing catastrophe occurs.
Confidentiality: Participation is kept strictly confidential from the public, employers, and the Board, provided the licensee adheres to the recovery contract.
Absence of Discipline: No formal disciplinary charges are filed against the license, and no disciplinary record is published on the Board's website or reported to the NABP Disciplinary Clearinghouse.
Preclusion: Voluntary status is inapplicable if the individual has engaged in felony commercial drug distribution, committed acts causing direct patient injury or death, or is already under active Board investigation.
Path B: Board-Ordered / Disciplinary Mandate (Public Track)
Origin: Triggered by a formal complaint, employer termination for on-duty impairment, arrest for controlled substance diversion, or an audit discovering missing drug stock.
Public Sanction: The Board issues an Agreed Order or Final Disciplinary Order placing the licensee on probation, suspending the license with a stay, or mandating PRP participation as a non-negotiable condition for reinstatement.
Transparency: The disciplinary order is a public record , published in the Board's newsletter and transmitted to the NABP Disciplinary Clearinghouse.
3. Core Components of the Recovery Contract
Whether enrolled voluntarily or via Board mandate, participants must execute a formal, legally binding Recovery and Monitoring Contract , typically spanning three (3) to five (5) years .
Standard Contractual Requirements
Comprehensive Clinical Evaluation: Multidisciplinary assessment at a Board-approved addiction treatment facility specializing in impaired healthcare professionals.
Inpatient or Intensive Outpatient Treatment: Completion of 30-day to 90-day residential treatment if clinically recommended.
Total Abstinence Agreement: Complete abstinence from all alcohol, controlled substances, mood-altering chemicals, and over-the-counter products containing alcohol, pseudoephedrine, or dextromethorphan, unless explicitly authorized in writing by a treating physician approved by the program.
Randomized Biological Drug Testing: Mandatory participation in unannounced, randomized drug screens (urine, hair follicle, blood, or Phosphatidylethanol / PEth testing) conducted under strict chain-of-custody protocols.
Support Group Attendance: Mandatory weekly attendance at 12-step recovery meetings (Alcoholics Anonymous / Narcotics Anonymous) and specialized healthcare professional / Caduceus peer support meetings.
Individual & Group Therapy: Regular sessions with an approved licensed addiction therapist.
4. Re-Entry to Practice & Practice Restrictions
Re-entering the pharmacy workplace is a carefully calibrated process requiring written authorization from the recovery program's medical director and the Board.
Initial Practice Limitations
To ensure a safe transition back to practice and reduce relapse triggers, returning pharmacists are typically subject to mandatory workplace restrictions for an initial period (usually 1 to 2 years):
No Solo Practice: The recovering pharmacist may not work as a solo practitioner; a second licensed pharmacist or designated monitor must be present on duty.
Prohibition on PIC Duties: The pharmacist is prohibited from serving as a Pharmacist-in-Charge (PIC).
Controlled Substance Restrictions: May be restricted from ordering, receiving, or managing Schedule II controlled substances.
Maximum Work Hours: Limited to no more than 40 hours per week (and no overnight / graveyard shifts).
Worksite Monitor: The employer must assign a designated pharmacist monitor who submits quarterly compliance reports to the recovery program.
5. Mandatory Duty to Report Impaired Colleagues
Oklahoma pharmacy law prioritizes patient safety above collegial loyalty. Under OAC 535:10-3-1.1 and the Code of Ethics for Pharmacists, licensees have an affirmative legal and professional duty to report colleagues who practice while impaired.
Who Must Be Reported?
Any licensed pharmacist, pharmacy intern, or registered pharmacy technician who is observed or suspected of practicing while impaired by:
- Alcohol or illicit narcotics;
- Diverted prescription controlled substances;
Severe physical or mental illness that compromises dispensing accuracy and judgment.
Where to Report?
Reports may be submitted directly to the Oklahoma State Board of Pharmacy or to the approved Pharmacists Recovery Program .
Employer / PIC Reporting Mandate: A Pharmacist-in-Charge or pharmacy permit holder who terminates a pharmacy employee for theft, diversion, or on-duty impairment must notify the Board of Pharmacy and OBNDD in writing within 14 days (or immediately if substantial diversion is identified).
Whistleblower Immunity & Protection
Under Oklahoma law, any individual who reports an impaired practitioner to the Board or the approved recovery program in good faith and without malice is immune from civil liability, defamation lawsuits, or retaliatory administrative claims.
6. Relapse, Non-Compliance & Emergency Revocation Protocols
Confidentiality within the recovery program is strictly contingent upon full and unwavering compliance with the recovery contract.
Immediate Notification Protocol
If a participant:
- Tests positive for alcohol, illicit drugs, or unauthorized controlled substances;
- Misses a scheduled random drug screen without an excused medical emergency;
- Leaves an inpatient treatment facility against medical advice (AMA); or
- Fails to attend mandatory Caduceus/12-step meetings or refuses therapy,
the program director is statutorily required to notify the Executive Director of the Oklahoma State Board of Pharmacy immediately .
Regulatory Consequences of Breach
Upon receiving notice of contract non-compliance, the Executive Director and Board legal counsel immediately petition the Board for an Emergency Summary Suspension under 75 O.S. § 314.1 . The pharmacist's license is suspended immediately to prevent imminent patient harm, and formal revocation proceedings are initiated.
7. Comparative Summary: Voluntary vs. Board-Ordered Recovery Track
Feature Voluntary Self-Referral Track Board-Ordered Disciplinary Track
Entry Trigger Self-referral or confidential peer report prior to Board investigation. Board complaint, arrest, workplace diversion, or disciplinary order.
Licensing Status Active (or voluntary inactive during initial rehab); no public discipline. Probation, stayed suspension, or condition of reinstatement.
Public Record Strictly confidential; exempt from open records disclosures. Public record; published in Board newsletter & NABP Clearinghouse.
Contract Length Typically 3 to 5 years of monitoring and drug testing. Typically 5 years (or indefinite) as dictated by Board order.
Relapse / Breach Immediate report to Board Executive Director; triggers emergency suspension. Immediate report to Board; triggers immediate license revocation.